Patent ID: 8840897
Filing Date: 2014-09-23
Classification: A61K,A61P,C07K

Abstract:
1. A method for the prophylactic treatment of neonatal alloimmune thrombocytopenia (NAIT), the method comprising the step of administering to a pregnant woman who is negative for the human platelet antigen HPA 1a, as well as negative for antibodies specific to the human platelet antigen HPA 1a, and who has received HPA 1a positive foetal platelets into her circulation from her HPA 1a positive foetus, a preparation comprising a sufficient quantity of antibodies to HPA 1a so as to substantially inhibit the woman's immune system from producing antibodies to HPA 1a wherein the preparation is administered to the woman before her own immune system starts to produce her own antibodies to the HPA 1a of the foetal platelets.